Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Baird

Showing results (721-730 of 784) with videos related to

Pageof 79
Sort By:
American Journal of Obstetrics and Gynecology|November 22, 2022
Abnormal uterine bleeding patterns determined through menstrual tracking among participants in the Apple Women's Health StudyCarey Y Zhang, Huichu Li, Shunan Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumoursH-T Arkenau, A Italiano, G Mak, et al.
Environmental Research|September 27, 2025
Estrogen-containing contraceptive use and blood lead concentrations in a cohort of premenopausal individualsLauren E Chapman, Mandy S Hall, Arianna Foster, et al.
Journal of Exposure Science & Environmental Epidemiology|June 24, 2024
Associations of per- and polyfluoroalkyl substances with uterine leiomyomata incidence and growth: a prospective ultrasound studyLauren A Wise, Chad M Coleman, Samantha Schildroth, et al.
American Journal of Epidemiology|May 28, 2024
A prospective cohort study of persistent endocrine-disrupting chemicals and perceived stressSamantha Schildroth, Amelia K Wesselink, Traci N Bethea, et al.
Frontiers in Oncology|February 28, 2022
Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid LeukemiaArthur Branstrom, Liangxian Cao, Bansri Furia, et al.
Journal of Women'S Health (2002)|November 19, 2020
Environmental Factors Involved in Maternal Morbidity and MortalityAbee L Boyles, Brandiese E Beverly, Suzanne E Fenton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumorsTimothy A Yap, Li Yan, Amita Patnaik, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2021
Reproductive Hormone Concentrations and Associated Anatomical Responses: Does Soy Formula Affect Minipuberty in Boys?Helen B Chin, Andrea Kelly, Margaret A Adgent, et al.
F&S Science|June 14, 2021
Summary of the Proceedings of the Basic Science of Uterine Fibroids Meeting: New Developments February 28, 2020Phyllis C Leppert, Ayman Al-Hendy, Donna D Baird, et al.
Pageof 79

Showing results (721-730 of 784) with videos related to

Sort By:
Pageof 79
American Journal of Obstetrics and Gynecology|November 22, 2022
Abnormal uterine bleeding patterns determined through menstrual tracking among participants in the Apple Women's Health StudyCarey Y Zhang, Huichu Li, Shunan Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumoursH-T Arkenau, A Italiano, G Mak, et al.
Environmental Research|September 27, 2025
Estrogen-containing contraceptive use and blood lead concentrations in a cohort of premenopausal individualsLauren E Chapman, Mandy S Hall, Arianna Foster, et al.
Journal of Exposure Science & Environmental Epidemiology|June 24, 2024
Associations of per- and polyfluoroalkyl substances with uterine leiomyomata incidence and growth: a prospective ultrasound studyLauren A Wise, Chad M Coleman, Samantha Schildroth, et al.
American Journal of Epidemiology|May 28, 2024
A prospective cohort study of persistent endocrine-disrupting chemicals and perceived stressSamantha Schildroth, Amelia K Wesselink, Traci N Bethea, et al.
Frontiers in Oncology|February 28, 2022
Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid LeukemiaArthur Branstrom, Liangxian Cao, Bansri Furia, et al.
Journal of Women'S Health (2002)|November 19, 2020
Environmental Factors Involved in Maternal Morbidity and MortalityAbee L Boyles, Brandiese E Beverly, Suzanne E Fenton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumorsTimothy A Yap, Li Yan, Amita Patnaik, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2021
Reproductive Hormone Concentrations and Associated Anatomical Responses: Does Soy Formula Affect Minipuberty in Boys?Helen B Chin, Andrea Kelly, Margaret A Adgent, et al.
F&S Science|June 14, 2021
Summary of the Proceedings of the Basic Science of Uterine Fibroids Meeting: New Developments February 28, 2020Phyllis C Leppert, Ayman Al-Hendy, Donna D Baird, et al.
Pageof 79